Ensure supply and safety of the national blood supply.

1. Establish policies
2. Expedite review of product applications
3. Conduct approval inspections
4. Oversee surveillance
5. Support enforcement activities

Encourage high risk donors to exclude themselves; update list of unsuitable donors; quarantine and test blood; investigate incidents to identify, and rectify common errors in blood banks.

All persons who may receive blood or blood products.

The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates.